Open AccessIs Clinical Exam of the Axilla Sufficient to Select Node-Positive Patients Who Downstage After NAC for SLNB? A Comparison of the Accuracy of Clinical Exam Versus MRI
Author(s) -
Tracy-Ann Moo,
Maxine S. Jochelson,
Emily C. Zabor,
Michelle Stempel,
Monica Raiss,
Anita Mamtani,
Audree B. Tadros,
Mahmoud ElTamer,
Monica Morrow
Publication year - 2019
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-019-07867-x
Subject(s) - medicine , lumpectomy , sentinel lymph node , axilla , breast cancer , biopsy , radiology , mastectomy , surgical oncology , lymph , cancer , lymph node , pathology
The National Comprehensive Cancer Network (NCCN) endorses sentinel lymph node biopsy (SLNB) in patients with clinically positive axillary nodes who downstage after neoadjuvant chemotherapy (NAC). In this study, we compared the accuracy of post-NAC MRI to clinical exam alone in predicting pathologic status of sentinel lymph nodes in cN1 patients.